News
NTUS
32.91
-0.60%
-0.20
Natus Medical Q1 EPS $0.22 Misses $0.26 Estimate, Sales $119.80M Beat $115.70M Estimate
Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.26 by 15.38 percent. This is a 37.5 percent increase over earnings of $0.16 per share from the
Benzinga · 05/05 20:43
Natus Medical Q1 Non-GAAP EPS, Revenue Rise
MT Newswires · 05/05 16:34
-- Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est of $0.26
MT Newswires · 05/05 16:31
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
U.S. stocks traded higher in volatile session, with the Dow Jones gaining around 60 points toward the end of trading on Monday.
Benzinga · 04/18 18:34
VIRX, ARQQ and GWGH among mid-day movers
Gainers: Casa Systems (CASA) +67%. CEL-SCI Corporation (CVM) +55%. Natus Medical (NTUS) +29%. Frequency Therapeutics (FREQ) +26%. GWG Holdings (GWGH) +20%. IMARA (IMRA) +19%. Iveda Solutions (IVDA) +18%. AgriFORCE (AGRI) +18%. Maris-Tech
Seekingalpha · 04/18 16:37
Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.
Benzinga · 04/18 16:36
34 Stocks Moving In Monday's Mid-Day Session
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.
Benzinga · 04/18 16:13
Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones adding around 100 points on Monday.
Benzinga · 04/18 14:55
Natus Medical, MedAvail top healthcare gainers; Nektar, TG Therapeutics lead losers' pack
Gainers: Natus Medical (NTUS) +30%. MedAvail (MDVL) +25%. IMARA (IMRA) +13%. Frequency Therapeutics (FREQ) +11%. Lyra Therapeutics (LYRA) +4%. Losers: Nektar Therapeutics (NKTR) -36%. TG Therapeutics (TGTX) -24%. Lixte Biotechnology (LIXT) -15%. Biofronter...
Seekingalpha · 04/18 14:00
Sector Update: Health Care
MT Newswires · 04/18 13:57
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 04/18 13:18
Natus Medical Soars. It’s Being Taken Private by ArchiMed for $1.2 Billion.
Dowjones · 04/18 12:37
BRIEF-Natus To Pay Prince Parent $19.8 Million If Merger Terminated For Alternative Deal Prior To Cut-Off Date
reuters.com · 04/18 12:32
NAT, OCX and ENSV among pre market gainers
Casa Systems (CASA) +41% as Verizon buys 9.9% stake. Natus Medical (NTUS) +28% to be acquired by Archimed Group for $33.50/share in cash or $1.2B. MedAvail Holdings (MDVL) +14%. IMARA (IMRA) +11%. Ocugen (OCGN) +7% on
Seekingalpha · 04/18 12:22
Natus Medical Agrees to Go Private in $1.2 Billion Deal With ArchiMed; Posts Higher Preliminary First-Quarter Revenue
MT Newswires · 04/18 11:40
Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal
Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion. 
Benzinga · 04/18 11:38
Natus Medical to be acquired at a 29% premium by ArchiMed
Natus Medical Inc. announced Monday a deal to be acquired in a deal valued at $1.2 billion by an affiliate of investment firm ArchiMed. Natus Medical's stock was still halted for news until 7:30 a.m. Eastern. Under terms of the deal, ArchiMed will pay $33....
marketwatch.com · 04/18 11:11
Natus Medical to be acquired by Archimed Group for $33.50/share in cash or $1.2B
Natus Medical (NASDAQ:NTUS) to be acquired by an affiliate of ArchiMed, an investment firm focused exclusively on the healthcare industry for ~$1.2B. Shareholders will receive $33.50 in cash for each
Seekingalpha · 04/18 11:11
ArchiMed to take medical device maker Natus private for $1.2 bln
reuters.com · 04/18 11:05
BRIEF-Natus Medical Posts Q1 Revenue Of $119.8 Million
reuters.com · 04/18 11:05
More
Webull provides a variety of real-time NTUS stock news. You can receive the latest news about Natus Medical through multiple platforms. This information may help you make smarter investment decisions.
About NTUS
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.